Showing results (221-230 of 1,074) with videos related to

Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|September 16, 2024
Efficacy and safety of patisiran for ATTRv-PN: a systematic review and meta-analysisXinyue Huang, Chong Sun, Haofeng Chen, et al.
Therapeutic Advances in Neurological Disorders|September 16, 2024
The Canadian Prospective Cohort Study to understand progression in multiple sclerosis: baseline characteristicsJiwon Oh, Nathalie Arbour, Fabrizio Giuliani, et al.
Therapeutic Advances in Neurological Disorders|September 24, 2024
CYP2C19 genotype and sodium channel blockers in lacosamide-treated children with epilepsy: two major determinants of trough lacosamide concentration or clinical responseYue Li, Hong-Li Guo, Jie Wang, et al.
Therapeutic Advances in Neurological Disorders|September 24, 2024
Maintenance of zilucoplan efficacy in patients with generalised myasthenia gravis up to 24 weeks: a model-informed analysisGuillemette de la Borderie, Damien Chimits, Babak Boroojerdi, et al.
Therapeutic Advances in Neurological Disorders|November 2, 2023
Corneal immune cells as a biomarker of inflammation in multiple sclerosis: a longitudinal studyIoannis N Petropoulos, Karen John, Fatima Al-Shibani, et al.
Therapeutic Advances in Neurological Disorders|November 2, 2023
Long-term efficacy and adverse effects of cannabidiol in adjuvant treatment of drug-resistant epilepsy: a systematic review and meta-analysisShengyi Liu, Zihua He, Jinmei Li
Therapeutic Advances in Neurological Disorders|October 9, 2023
Epileptic seizures at multiple sclerosis onset and their role in disease progressionMatthias Grothe, David Ellenberger, Paulus S Rommer, et al.
Therapeutic Advances in Neurological Disorders|July 19, 2023
Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi methodRalf Gold, Michael Barnett, Andrew Chan, et al.
Therapeutic Advances in Neurological Disorders|September 1, 2023
Pharmacological diversity amongst approved and emerging antiseizure medications for the treatment of developmental and epileptic encephalopathiesGraeme J Sills
Therapeutic Advances in Neurological Disorders|June 26, 2023
Magnetic Resonance-guided Focused Ultrasound thalamotomy for refractory neuropathic pain: a systematic review and critical appraisal of current knowledgeValentina Taranta, Gennaro Saporito, Raffaele Ornello, et al.
Pageof 108